These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26043737)

  • 1. Electrohydrodynamic Preparation of Nanomedicines.
    Rasekh M; Smith A; Arshad MS; Gunduz O; Van der Merwe SM; Smith G; Ahmad Z
    Curr Top Med Chem; 2015; 15(22):2316-27. PubMed ID: 26043737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating Nanomedicines: Obstacles and Advancements.
    Swierczewska M; Crist RM; McNeil SE
    Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical and biomaterial engineering via electrohydrodynamic atomization technologies.
    Mehta P; Haj-Ahmad R; Rasekh M; Arshad MS; Smith A; van der Merwe SM; Li X; Chang MW; Ahmad Z
    Drug Discov Today; 2017 Jan; 22(1):157-165. PubMed ID: 27693432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in green nanoparticulate systems for drug delivery: efficient delivery and safety concern.
    Lam PL; Wong WY; Bian Z; Chui CH; Gambari R
    Nanomedicine (Lond); 2017 Feb; 12(4):357-385. PubMed ID: 28078952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EHDA Spraying: A Multi-Material Nano-Engineering Route.
    Haj-Ahmad R; Rasekh M; Nazari K; Li Y; Fu Y; Li B; Zhang Q; Xia Z; Liu H; Gu T; Wang G; Kucuk I; Khan H; Arshad MS; Li X; Ahmad Z
    Curr Pharm Des; 2015; 21(22):3239-47. PubMed ID: 26027562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymeric Based Therapeutic Delivery Systems Prepared Using Electrohydrodynamic Processes.
    Rasekh M; Nazari K; Arshad MS; Kucuk I; Haj-Ahmad R; Hussain A; Morris MA; Abbas N; Chang MW; Li X; Ahmad Z
    Curr Pharm Des; 2016; 22(19):2873-85. PubMed ID: 26898734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrohydrodynamic atomisation driven design and engineering of opportunistic particulate systems for applications in drug delivery, therapeutics and pharmaceutics.
    Ali A; Zaman A; Sayed E; Evans D; Morgan S; Samwell C; Hall J; Arshad MS; Singh N; Qutachi O; Chang MW; Ahmad Z
    Adv Drug Deliv Rev; 2021 Sep; 176():113788. PubMed ID: 33957180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Toxicological Considerations of Nanomedicines: The Future Directions.
    Patel P; Shah J
    Curr Clin Pharmacol; 2017; 12(2):73-82. PubMed ID: 28486906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tunable resistive pulse sensing: potential applications in nanomedicine.
    Sivakumaran M; Platt M
    Nanomedicine (Lond); 2016 Aug; 11(16):2197-214. PubMed ID: 27480794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomedical engineering: shaping future nanomedicines.
    Luo D; Carter KA; Lovell JF
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(2):169-88. PubMed ID: 25377691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulus-responsive targeted nanomicelles for effective cancer therapy.
    Muthu MS; Rajesh CV; Mishra A; Singh S
    Nanomedicine (Lond); 2009 Aug; 4(6):657-67. PubMed ID: 19663594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical and dental applications of nanomedicines.
    Kavoosi F; Modaresi F; Sanaei M; Rezaei Z
    APMIS; 2018 Oct; 126(10):795-803. PubMed ID: 30264432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrospinning of polymeric nanofibers for drug delivery applications.
    Hu X; Liu S; Zhou G; Huang Y; Xie Z; Jing X
    J Control Release; 2014 Jul; 185():12-21. PubMed ID: 24768792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical Amorphous Nanoparticles.
    Jog R; Burgess DJ
    J Pharm Sci; 2017 Jan; 106(1):39-65. PubMed ID: 27816266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrospun inorganic and polymer composite nanofibers for biomedical applications.
    Sridhar R; Sundarrajan S; Venugopal JR; Ravichandran R; Ramakrishna S
    J Biomater Sci Polym Ed; 2013; 24(4):365-85. PubMed ID: 23565681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities.
    Farjadian F; Ghasemi A; Gohari O; Roointan A; Karimi M; Hamblin MR
    Nanomedicine (Lond); 2019 Jan; 14(1):93-126. PubMed ID: 30451076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders.
    Muthu MS; Singh S
    Nanomedicine (Lond); 2009 Jan; 4(1):105-18. PubMed ID: 19093899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pH-sensitive nano-systems for drug delivery in cancer therapy.
    Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
    Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomedicines: Redefining traditional medicine.
    Lu W; Yao J; Zhu X; Qi Y
    Biomed Pharmacother; 2021 Feb; 134():111103. PubMed ID: 33338747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanostructuring molecular materials as particles and vesicles for drug delivery, using compressed and supercritical fluids.
    Elizondo E; Veciana J; Ventosa N
    Nanomedicine (Lond); 2012 Sep; 7(9):1391-408. PubMed ID: 22994957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.